logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • beta2-Adrenergic Agonist class drugs

    FiltersReset Filters
    25 results

    • advair

      (fluticasone propionate and salmeterol)
      GlaxoSmithKline LLC
      Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.

    • advair hfa

      (fluticasone propionate and salmeterol xinafoate)
      GlaxoSmithKline LLC
      Usage: ADVAIR HFA is indicated for the treatment of asthma in adults and adolescents aged 12 and older who are not adequately controlled on long-term asthma medications or require both an inhaled corticosteroid and a long-acting beta2-adrenergic agonist. It is not for acute bronchospasm relief.

    • albuterol sulfate

      (Albuterol Sulfate)
      Sandoz Inc
      Usage: Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 years and older with reversible obstructive airway disease and for preventing exercise-induced bronchospasm.

    • albuterol sulfate

      (Albuterol Sulfate)
      Ritedose Pharmaceuticals, LLC
      Usage: Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and for managing acute bronchospasm attacks.

    • albuterol sulfate

      (Albuterol Sulfate)
      Nephron Pharmaceuticals Corporation
      Usage: Albuterol inhalation solution is indicated for the relief of bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and during acute bronchospasm attacks.

    • albuterol sulfate

      (Albuterol Sulfate)
      Armstrong Pharmaceuticals, Inc.
      Usage: Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 and older with reversible obstructive airway disease, as well as for preventing exercise-induced bronchospasm in the same age group.

    • albuterol sulfate inhalation solution

      (Albuterol Sulfate)
      Ritedose Pharmaceuticals, LLC
      Usage: Albuterol Sulfate Inhalation Solution is indicated for relieving bronchospasm in patients aged 2 to 12 years with asthma (reversible obstructive airway disease).

    • albuterol sulfate inhalation solution, 0.5%

      (Albuterol Sulfate)
      Ritedose Pharmaceuticals, LLC
      Usage: Albuterol sulfate inhalation solution is indicated for relieving bronchospasm in patients aged 12 and older with reversible obstructive airway disease and during acute bronchospasm attacks.

    • anoro ellipta

      (umeclidinium bromide and vilanterol trifenatate)
      GlaxoSmithKline LLC
      Usage: ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.

    • arformoterol tartrate

      (Arformoterol tartrate)
      Alembic Pharmaceuticals Inc.
      Usage: Arformoterol tartrate inhalation solution is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, via nebulization. It is not intended for acute COPD exacerbations or for treating asthma.